About: protein based vaccine

Coronavirus 20-12-2021

Nuvaxovid, fifth vaccine against COVID, authorised in EU

The European Commission has granted conditional marketing authorisation for US biotech firm Novavax’s COVID-19 vaccine, Nuvaxovid, on Monday (20 December) following the European Medicines Agency (EMA) recommendation.